Form4insider filings, from the source

SEC Form 4 · accession 0000921895-17-002744

Enveric Biosciences, Inc. · ENVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jeffrey E. Eberwein
Director · 10% Owner
Period of report
Nov 17, 2017
Accepted (ET)
Nov 21, 2017 · 4:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F4Nov 17, 2017P100,000$4.115A2,972,592IBy: Lone Star Value Investors, LP
Common StockF1holding———27,066D
Common StockF1,F2holding———83,308IBy: Separately Managed Account
Common StockF1,F3holding———13,910IBy: Lone Star Value Co-Invest I, LP
9.00% Series A Cumulative Preferred StockF1,F4holding———383,985IBy: Lone Star Value Investors, LP

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Warrant (Right to Buy)F5,F4$4.115Nov 17, 2017P100,000ANov 17, 2017Nov 21, 2022Common Stock100,000100,000I

Explanation of responses